What do I need to qualify for Ozempic?

In the ever-evolving landscape of weight management medications, GLP-1 agonists like Wegovy, Ozempic, and Mounjaro have become household names. As these medications grow in popularity, many patients wonder if they can access them conveniently through telehealth services rather than scheduling multiple in-person visits. The answer is generally yes, but with some important state-specific considerations.

Telehealth Access to GLP-1 Medications: The Basics

Good news: You can legally access GLP-1 weight loss medications through telehealth in most U.S. states. Since these medications are not controlled substances, federal law does not require an in-person visit before prescribing them. This makes them more accessible via telehealth than medications like stimulants or certain pain medications.

At Klarity Health, our providers can evaluate you through a comprehensive telehealth consultation and, if appropriate, prescribe GLP-1 medications electronically to your local pharmacy. However, state laws and regulations create a patchwork of requirements that affect how these medications can be prescribed.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Requirements for Weight Loss Medications

While telehealth prescribing of GLP-1s is generally available nationwide, several states impose additional requirements. Let’s break down the key differences:

States With No In-Person Exam Requirement

These states allow GLP-1 medications to be prescribed via telehealth without any mandatory in-person examination:

• California: Fully embraces telehealth with no in-person requirements for weight loss medications
• Connecticut: Allows telehealth prescribing but requires behavioral counseling alongside medication
• Florida: Permits telehealth prescribing but requires BMI ≥30 and follow-up visits at least every 3 months
• Illinois: No special restrictions for telehealth weight loss prescribing
• New York: Embraces telehealth without special restrictions for weight loss medications
• Pennsylvania: No in-person mandate for GLP-1 prescribing
• Washington: Pioneer in telehealth access with no special restrictions

States Requiring an Initial In-Person Examination

These states require an in-person physical examination before or soon after starting telehealth treatment:

• Arkansas: One of the more restrictive states, requires initial in-person exam
• Delaware: Requires an initial in-person exam before telehealth prescribing
• Georgia: Mandates an initial in-person examination for weight loss medications
• Mississippi: State law requires an in-person evaluation for weight management therapy
• New Jersey: Requires comprehensive in-person exam plus laboratory work
• North Dakota: Expects an in-person initial evaluation for weight loss treatment
• South Carolina: Requires in-person examination before telehealth weight loss prescribing
• Texas: Generally expects an initial in-person exam for standard of care
• Utah: Recommends in-person baseline evaluation
• Virginia: Requires initial physical exam, lab work, and a personalized diet/exercise plan

Who Can Prescribe GLP-1 Medications via Telehealth?

Provider qualifications vary by state, which affects who you might see during a telehealth consultation:

Medical Doctors and Doctors of Osteopathy

All states allow MDs and DOs to prescribe GLP-1 medications via telehealth, assuming they’re licensed in your state.

Nurse Practitioners (NPs) and Physician Assistants (PAs)

• States with Full Independent Practice Authority for NPs: California, Connecticut, New York, North Dakota, Utah, Virginia, Washington (NPs can prescribe independently)
• States Requiring Collaboration/Supervision: Arkansas, Delaware, Florida, Georgia, Illinois, Mississippi, New Jersey, Pennsylvania, South Carolina, Texas (NPs/PAs need physician oversight)

At Klarity Health, we ensure all our providers are appropriately licensed and credentialed according to your state’s requirements, giving you confidence in the legitimacy of your care.

Patient Eligibility for GLP-1 Medications

Contrary to some misconceptions, GLP-1 medications aren’t appropriate for everyone looking to lose weight. Reputable telehealth providers conduct thorough evaluations to determine if these medications are right for you.

Generally, you may qualify if you have:

• A BMI of 30 or higher (obesity), or
• A BMI of 27 or higher with at least one weight-related condition (like high blood pressure, type 2 diabetes, or high cholesterol)

You’ll need to provide your health history, current measurements, and commit to a treatment plan that includes lifestyle modifications. Providers will also screen for contraindications, including pregnancy, personal or family history of medullary thyroid carcinoma, and severe gastrointestinal disorders.

The Telehealth Prescription Process

When seeking GLP-1 medications through telehealth, expect a process that typically includes:

1. Comprehensive Intake: Complete a detailed health questionnaire covering your medical history, current medications, allergies, and weight management goals.

2. Video Consultation: Meet with a healthcare provider who will review your information, discuss treatment options, and determine if a GLP-1 medication is appropriate for you.

3. Personalized Treatment Plan: If prescribed, you’ll receive a plan that includes medication instructions, dietary recommendations, and exercise guidance.

4. Regular Follow-ups: Most telehealth programs include regular check-ins to monitor your progress, adjust dosing if needed, and address any side effects.

5. Prescription Management: Electronic prescriptions sent directly to your local pharmacy, with refills managed according to your state’s regulations.

At Klarity Health, we prioritize this thorough approach, ensuring you receive appropriate care that meets or exceeds in-person standards.

Red Flags to Watch For

The popularity of GLP-1 medications has unfortunately led to some questionable telehealth practices. Be wary of services that:

• Guarantee a prescription without a proper evaluation
• Sell ‘compounded’ versions of semaglutide (the FDA banned most compounding in 2025)
• Don’t require follow-up appointments
• Lack transparency about provider credentials or licensing
• Skip discussing risks, side effects, and alternatives

Looking Forward: The Future of Telehealth for Weight Management

Telehealth prescribing of GLP-1s is likely here to stay, with ongoing regulatory developments generally trending toward greater access with appropriate safeguards. As of late 2025, the telehealth landscape continues to evolve, with many states expanding practice authority for NPs and PAs and streamlining telehealth requirements.

For patients, this means continued or even improved access to these medications through telehealth platforms. Klarity Health remains committed to staying current with all regulatory changes to ensure our patients receive compliant, high-quality care no matter where they live.

Conclusion

Access to GLP-1 medications through telehealth is available nationwide, though requirements vary by state. By understanding your state’s specific rules and working with a reputable telehealth provider like Klarity Health, you can access these medications safely and conveniently.

If you’re considering GLP-1 medications for weight management, schedule a consultation with one of our licensed providers who can evaluate your specific situation, discuss treatment options, and guide you through the process in compliance with your state’s regulations.

FAQ

Q: Are GLP-1 medications like Wegovy controlled substances?
A: No, GLP-1 medications (Wegovy, Ozempic, Mounjaro) are not controlled substances, which is why they can be prescribed via telehealth without the restrictions that apply to medications like Adderall or certain pain medications.

Q: What’s the difference between Wegovy and Ozempic?
A: Both contain semaglutide but are FDA-approved for different purposes: Wegovy (2.4mg) for chronic weight management and Ozempic (0.5-1mg) for Type 2 diabetes. Ozempic is sometimes prescribed off-label for weight loss.

Q: Will insurance cover GLP-1 medications prescribed through telehealth?
A: Insurance coverage varies widely. Some plans cover these medications with prior authorization, while others consider them ‘lifestyle drugs’ and don’t provide coverage. At Klarity Health, we can help you navigate insurance options or provide transparent cash pricing.

Q: How often will I need follow-up appointments?
A: Most providers recommend follow-ups 1 month after starting, then every 2-3 months. Some states mandate specific follow-up schedules (e.g., Florida requires at least one visit every 3 months).

Q: Can I get a 90-day supply of my GLP-1 medication?
A: Possibly, depending on your state, insurance, and how long you

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid